SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-005726
Filing Date
2017-05-22
Accepted
2017-05-22 14:26:34
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 426881
2 ex31-1.htm EX-31.1 11029
3 ex31-2.htm EX-31.2 11398
4 ex32-1.htm EX-32.1 7137
5 ex32-2.htm EX-32.2 7106
  Complete submission text file 0001493152-17-005726.txt   3105132

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE obmp-20170331.xml EX-101.INS 424152
7 XBRL SCHEMA FILE obmp-20170331.xsd EX-101.SCH 34437
8 XBRL CALCULATION FILE obmp-20170331_cal.xml EX-101.CAL 51236
9 XBRL DEFINITION FILE obmp-20170331_def.xml EX-101.DEF 174366
10 XBRL LABEL FILE obmp-20170331_lab.xml EX-101.LAB 297688
11 XBRL PRESENTATION FILE obmp-20170331_pre.xml EX-101.PRE 246050
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 17860576
SIC: 2834 Pharmaceutical Preparations